Objective-To measure the potential for secondary prevention of coronary disease in the United Kingdom. Design-Cross sectional survey of a representative sample of coronary patients from a retrospective review of hospital medical records and patient interview and examination.
Setting-Stratified random sample of 12 specialist cardiac centres and 12 district general hospitals drawn from 34 specialist cardiac centres and 261 district general hospitals in 12 geographic areas in the United Kingdom. Subjects-2583 patients < 70 yr; 25 consecutive males and 25 consecutive females identified retrospectively in each of four diagnostic categories: coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, acute myocardial infarction, and acute myocardial ischaemia without evidence of infarction. Main outcome measures-Risk factor recording and management in medical records; the prevalence and control of risk factors at interview six months after the procedure or event.
Results-Recording of coronary risk factors in patient's records was incomplete and this varied by risk factor. Smoking habit and blood pressure were most completely recorded, whereas a history of hyperlipidaemia and blood cholesterol concentrations were least complete. Risk factor records were more likely to be complete in cardiac centres than in district hospitals. At interview 10%Yo to 27% of patients were still smoking cigarettes and 75% remained overweight, females more severely so. Up to a quarter of patients remained hypertensive, males more severely so than females. Over three quarters had a total cholesterol > 5 2 mmol/l. In patients on medication for blood pressure, cholesterol or glucose, risk factor profiles were little better than in those who were not. Only about one patient in three was taking a ,B blocker after infarction. Up to a fifth of patients who had had acute myocardial ischaemia were not taking aspirin at follow up.
Conclusions-There is considerable potential to reduce the risk of a further major ischaemic event in patients with established coronary disease. This can be achieved by effective lifestyle intervention, the rigorous management of blood pressure and cholesterol, and the appropriate use of prophylactic drugs. (Heart 1996; 75:334-342) Keywords: coronary disease; secondary prevention; United Kingdom survey Since the last British Cardiac Society report' on prevention of coronary disease in 1987, a considerable amount of new scientific evidence has been published on interventionslifestyle,2A the control of coronary risk factors5-7 and the use of prophylactic drug treatment8-"1-showing that the risk of a further major ischaemic event in patients with established coronary disease can be reduced. In June 1993, the British Cardiac Society Epidemiology and Prevention Committee convened a Workshop on Preventive Cardiology in London, which was attended by representatives of cardiac centres throughout the United Kingdom. The aim was to discuss strategies beyond symptom relief with medical treatment and revascularisation, which can reduce the risk of (re)infarction and to improve survival. As a result of these discussions, the Epidemiology and Prevention Committee decided to survey the extent to which coronary risk factors are being measured and recorded in clinical practice and how effectively they are managed in coronary patients.
The specific aims of ASPIRE ( Scotland divided into east and west). One cardiac centre and one district general hospital were drawn at random from each geographic stratum and were invited to participate in the survey. All 12 cardiac centres agreed to participate; however, three of the district general hospitals declined. These were replaced in the sample by three district general hospitals randomly selected from the same regions as those hospitals that had declined to participate. All three substitutes agreed to participate. PATIENT 
SAMPLE
Administrative records of coronary revascularisation procedures from the cardiac centres and of consultant episodes (deaths and discharges) from the district general hospitals were obtained. Starting from a date six months before the start of the survey, these records were searched chronologically in reverse order, and 25 consecutive males and 25 consecutive females were identified in each of the four diagnostic categories from each of the 12 geo- *Proportions with a measurement recorded in the notes before the index event, after the index event, or ever (either before or after the index event). Denominator includes patients for whom notes were unavailable-as shown in fig 1. ] Not recorded * No action [ Action Use of a sample size of 300 subjects in each sex-specific diagnostic category allows prevalence of 50% to be estimated with a 95% confidence interval of 44% to 56%: prevalences above or below 50% are estimated increasingly more precisely.
Results

PATIENTS
Information on a total of 2583 patients (male median age 59 (range 27-70), female median age 62 (range 26-70)) was collected (table 1) . One hundred and ninety nine patients had died by the time of interview and were replaced in the sample with the object of achieving the target quota of 300 living patients in each of the eight sex and diagnosis specific subgroups. All 2384 survivors were invited for interview and 83% attended. could not be retrieved (fig 1) . Figure 1 shows the proportion of patients with risk factor histories of smoking, hypertension, hyperlipidaemia, diabetes, and family history recorded in the medical notes.
Risk factor measurements Table 2 shows the proportions of patients with coronary risk factor measurements recorded in the medical notes, either before or after the index event. Figure 2 displays the doctor's response recorded in the medical notes to current smoking and to five risk factor values above a specified threshold: BMI > 30 kg/M2, systolic blood pressure > 160 mm Hg, diastolic blood pressure > 100 mm Hg, total cholesterol > 6-5 mmol/l, and blood glucose > 10 mmol/l. For all four diagnostic groups, the risk factor measurement used was the first available in the notes. For each subgroup, the denominator given in fig 2 is the number of patients recorded as having a value above the specified threshold. The action taken was defined as any of the following-further measurements made, general lifestyle advice given, specific advice given by nutritionist, medication started. PATIENT 
INTERVIEWS
Risk factors reported and measured Table 3 shows the prevalence of risk factor values measured at interview. Current smoking habit was validated by breath carbon monoxide concentrations > 10 ppm.
Therapeutic control of risk factors by medication Table 4 shows the control of blood pressure, total cholesterol, and glucose in those on and not on medication at interview. Family history and screening of blood relatives Table 5 shows the reported family history and screening of blood relatives.
Reported drug treatment Table 6 shows the prevalence of reported drug treatment at interview. Discussion This national survey of coronary patients found that recording and management of risk factors-lifestyle, blood pressure, cholesterol, glucose-and the use of prophylactic drug treatment were less than optimal. This finding demonstrates the real clinical potential to reduce further the subsequent risk of morbidity and mortality. Because consecutive patients were identified from a random sample of specialist cardiac centres and district general hospitals, these results are likely to be representative of hospital risk factor recording for coronary patients throughout the country. For practical reasons, the review of patients' records was restricted to hospital notes. This may underestimate the real extent to which coronary risk factors are recorded in all parts of medical practice. However, the results of interviewing patients at least six months after the hospital procedure or admission, summate the contributions to risk factor management of hospitals and general practice and the responses of patients.
Recording of the history of risk factor exposure and of risk factor measurements varied considerably between and within diagnostic groups. Smoking history was most frequently recorded and hyperlipidaemia history least frequently: the latter being absent in over 40% of cases. This pattern was similar across diagnostic groups and by gender. However, except for smoking history, the proportion of absent risk factor histories was much greater in the groups with AMI and myocardial ischaemia than in the revascularisation groups, for both men and women. Risk factor measurements showed a similar variation, with blood pressure most frequently recorded and total cholesterol least frequently. Again risk factor measurements in the CABG and PTCA patients were more complete than in the other groups but this consistent observation must partly reflect the length of time these patients had been under medical care compared with AMI and myocardial ischaemia patients.
A record of action in response to a patient's risk factor measurements also showed considerable variation. This was true whether the analysis was based on the first observed risk factor measurement, or on the highest risk factor value recorded in the notes. Action was most frequently recorded in response to blood pressure, then to blood glucose, total cholesterol, body mass index and least frequently in response to current cigarette smoking. The absence of a written record of action is not synonymous with no action because, for example, it seems most unlikely that current smokers were not advised to stop but rather that such action was not regarded as sufficiently important to record in the patient's notes. With some exceptions there was a tendency for action to be recorded more frequently for women than for men. However, by the time of interview, up to a quarter of patients were still smoking cigarettes, validated by breath carbon monoxide, and 339 group.bmj.com on June 23, 2017 -Published by http://heart.bmj.com/ Downloaded from ASPIRE Steenng Group most were still overweight and some were severely so. The proportion of women who continued to smoke after AMI was greater than the proportion of men, and in every diagnostic group the severity of obesity (BMI . 30 kg/M2) was greater in women. Stopping smoking,'2 modifying diet (decreasing saturated fats and increasing polyunsaturated fats particularly from omega 3 sources),23' and taking more aerobic exercise4 are all important steps towards reducing the risk of further morbidity and mortality. In making these lifestyle changes, patients also reduce the need for physicians to intervene with drugs in relation to blood pressure, lipoproteins, and glucose.
The British Hypertension Society (BHS), in its management guidelines for essential hypertension,'4 recommends treatment of a diastolic blood pressure > 90 mm Hg for coronary patients. About a quarter of patients in this survey were above this threshold, and about a fifth were . 100 mm Hg. About 7% of patients in each diagnostic category were eligible for treatment according to the BHS combination of a systolic blood pressure between 160 and 200 mm Hg, combined with a diastolic pressure of 95 mm Hg or more. Of those on antihypertensive treatment at interview up to a third still had diastolic blood pressures > 90 mm Hg. As the recommended treatment goal is to reduce diastolic blood pressure to less than 90 mm Hg these results represent inadequate antihypertensive control.
In the British Hyperlipidaemia Association's (BHA) guidelines,'5 patients with existing coronary disease are defined as the first priority for action if their total cholesterol is > 5-2 mmol/l on optimal diet. 72% of the men and 83% of the women in this survey had a total cholesterol > 5'2 mmol/l at least six months after the pro- This survey was conducted at one point in the clinical course of the disease which varied between diagnostic groups and between patients within groups. Nearly two thirds of the AMI patients were incident cases, with no history of coronary disease before their index admission, whereas over two thirds of patients with myocardial ischaemia had a previous history of coronary disease. Thus, this survey does not underestimate recording and management of coronary risk factors, as the longer the interval between disease onset and patient interview, the more opportunity there was for intervention. A minimum period of six months after the index procedure or event was set before records were abstracted and patients interviewed, as this -was deemed a sufficiently long interval in which to assess and manage the major coronary risk factors. For most patients in this survey, the interval between disease onset and patient interview was considerably longer.
In 
